Drug Excipient Compatibility Testing Protocols and Charaterization: A Review
Asian Journal of Chemical Sciences,
Drug molecule contains various reactive functional groups which are susceptible to react with another reactive functional groups which might be excipients, excipient or drugs impurities formed during manufacturing or storage. The objective of the current review article is to provide a comprehensive review of excipients-drug compatibility study, their degradation product characterization with different analytical methods and further impact of methodologies in pharmaceutical industry for potential stability assessment. The incompatibility of drug excipient was very common due to the reactive functional groups in drugs and excipients. These leads to formation of drug related impurities as well as excipient impurities reaction with active Pharmaceutical Ingredients. Sometimes these impurities found to be mutagenic and genotaxic to human beings. Identification of drug degradation in presence of excipient impurities requires extensive knowledge and adequate analytical characterization data. Systematic literature review and understanding about the drug-excipient chemistry in formulation process is important criteria to select compatible excipient and formulate ideal formulation. The analytical characterization data gives idea about degradation pathway. This paper discusses drug-excipient interactions, compatibility and characterization by different analytical methods with case studies and provides an overview of different excipients compatibility in formulation.
- Different excipients
- reactive functional groups
- degradation products
How to Cite
Narang AS, Rao VM, Raghavan KS. Excipient compatibility. In developing solid oral dosage forms. Academic Press. 2009:125-45.
Jinnawar KS, Gupta KR. Drug excipient compatibility study using thermal and non-thermal methods of analysis. Int J Chem tech Applications. 2012;2(2):23-49.
Keraliya vipul. Drug-excipient compatibility studies.
(Accessed on: 16 July 2019)
DiFeo TJ. Drug product development: A technical review of chemistry, manufacturing and controls information for the support of pharmaceutical compound licensing activities. Drug development and industrial pharmacy. 2003;29(9):939-58.
Bharate SS, Bharate SB, Bajaj AN. Interactions and incompatibilities of pharmaceutical excipients with active pharmaceutical ingredients: A comprehensive review. Journal of Excipients and Food Chemicals. 2016;1(3): 1131.
Lund MN, Ray CA. Control of Maillard reactions in foods: Strategies and chemical mechanisms. Journal of Agricultural and Food Chemistry. 2017;65 (23):4537-52.
Mauron J. The Maillard reaction in food. Prog. Fd. Nutr. Sci. 1981;5:5-35.
Monajjemzadeh F, Hassanzadeh D, Valizadeh H, Siahi-Shadbad MR, Mojarrad JS, Robertson T, Roberts MS. Assessment of feasibility of Maillard reaction between baclofen and lactose by liquid chromatography and tandem mass spectrometry, application to pre-formulation studies. AAPS Pharm Sci Tech. 2009;10(2):649-59.
Ghaderi F, Nemati M, Siahi-Shadbad MR, Valizadeh H, Monajjemzadeh F. DSC kinetic study of the incompatibility of doxepin with dextrose. Journal of Thermal Analysis and Calorimetry. 2016; 123(3):2081-90.
Wirth DD, Baertschi SW, Johnson RA, Maple SR, Miller MS, Hallenbeck DK, Gregg SM. Maillard reaction of lactose and fluoxetine Hydrochloride, a secondary amine. Journal of Pharmaceutical Sciences. 1998;87(1):31-9.
Rystov L, Chadwick R, Krock K, Wang T. Simultaneous determination of Maillard reaction impurities in memantine tablets using HPLC with charged aerosol detector. Journal of Pharmaceutical and Biomedical Analysis. 2011;56(5):887-94.
Gumieniczek A, Berecka A, Mroczek T, Wojtanowski K, Dąbrowska K, Stępień K. Determination of chemical stability of sitagliptin by LC-UV, LC-MS and FT-IR methods. Journal of Pharmaceutical and Biomedical Analysis. 2019;164:789-807.
Kurmi M, Sahu A, Ladumor MK, Bansal AK, Singh S. Stability behaviour of antiretroviral drugs and their combinations. 9: identification of incompatible excipients. Journal of Pharmaceutical and Biomedical Analysis. 2019;166:174-82.
Patil DD, Patil CR. Modification of pharmacological activity of nebivolol due to Maillard reaction. Pharmaceutical Development and Technology. 2013;18(4): 844-51.
Delaney SP, Nethercott MJ, Mays CJ, Winquist NT, Arthur D, Calahan JL, Sethi M, Pardue DS, Kim J, Amidon G, Munson EJ. Characterization of synthesized and commercial forms of magnesium stearate using differential scanning calorimetry, thermogravimetric analysis, powder X-ray diffraction and solid-state NMR spectroscopy. Journal of Pharmaceutical Sciences. 2017;106(1):338-47.
Stanisz B, Regulska K, Kania J, Garbacki P. Effect of pharmaceutical excipients on the stability of angiotensin-converting enzyme inhibitors in their solid dosage formulations. Drug Development and Industrial Pharmacy. 2013;39(1):51-61.
Kumar V, Kalonia DS. Removal of peroxides in polyethylene glycols by vacuum drying: Implications in the stability of biotech and pharmaceutical formulations. AAPS Pharmscitech. 2006;7 (3):E47.
Dyakonov T, Muir A, Nasri H, Toops D, Fatmi A. Isolation and characterization of cetirizine degradation product: Mechanism of cetirizine oxidation. Pharmaceutical Research. 2010;27(7):1318-24.
Schou‐Pedersen AM, Hansen SH, Moesgaard B, Østergaard J. Kinetics of the esterification of active pharmaceutical ingredients containing carboxylic acid functionality in polyethylene glycol: Formulation implications. Journal of Pharmaceutical Sciences. 2014;103(8): 2424-33.
Nykänen P, Lempää S, Aaltonen ML, Jürjenson H, Veski P, Marvola M. Citric acid as excipient in multiple-unit enteric-coated tablets for targeting drugs on the colon. International Journal of Pharmaceutics. 2001;229(1-2):155-62.
Gressl C, Brunsteiner M, Davis A, Landis M, Pencheva K, Scrivens G, Sluggett GW, Wood GP, Gruber-Woelfler H, Khinast JG, Paudel A. Drug–excipient interactions in the solid state: The role of different stress factors. Molecular Pharmaceutics. 2017;14 (12):4560-71.
Menning MM, Dalziel SM. Fumaric acid microenvironment tablet formulation and process development for crystalline cenicriviroc mesylate, a BCS IV compound. Molecular Pharmaceutics. 2013;10(11):4005-15.
Wu Y, Levons J, Narang AS, Raghavan K, Rao VM. Reactive impurities in excipients: Profiling, identification and mitigation of drug–excipient incompatibility. AAPS Pharm Sci Tech. 2011;12(4):1248-63.
Gibala P, Douša M, Kalužíková A, Tkadlecová M, Štefko M, Kalášek S, Břicháč J. Identification and structure elucidation of a new degradation impurity in the multi-component tablets of amlodipine besylate. Journal of Pharmaceutical and Biomedical Analysis. 2019;162:112-6.
Barmi Hartesi1,2, Sriwidodo2, Marline Abdassah2, Anis Yohana Chaerunisaa. Starch as pharmaceutical excipient. Int. J. Pharm. Sci. Rev. Res. 2016;14: 59-64.
Selvam K, Swaminathan M. Photocatalytic synthesis of 2-methylquinolines with TiO2 Wackherr and home prepared TiO2 – A comparative study. Arabian Journal of Chemistry. 2017;10:S28-34.
Abramović B, Kler S, Šojić D, Laušević M, Radović T, Vione D. Photocatalytic degradation of metoprolol tartrate in suspensions of two TiO2-based photocatalysts with different surface area. Identification of Intermediates and Proposal of Degradation Pathways. Journal of Hazardous Materials. 2011;198: 123-32.
Misic Z, Jung DŠ, Sydow G, Kuentz M. Understanding the interactions of oleic acid with basic drugs in solid lipids on different biopharmaceutical levels. Journal of Excipients and Food Chemicals. 2016;5(2): 950.
Yarkala S, Amaravadi S, Rao VU, Navalgund SG, Jagdish B. Role of excipients on N-oxide raloxifene generation from raloxifene–excipients binary mixtures. Chemical and Pharmaceutical Bulletin. 2009;57(10): 1174-7.
Baertschi SW, Alsante KM. Stress testing: The chemistry of drug degradation. In Pharmaceutical Stress Testing. CRC Press. 2016;61-153.
Abstract View: 2927 times
PDF Download: 1293 times